Psyence Historical Financial Ratios
| PBMWW Stock | 0.01 0.0005 6.76% |
Psyence Biomedical is promptly reporting on over 67 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Free Cash Flow Yield of 0.0, Invested Capital of 0.0, Operating Cash Flow Per Share of 0.0 or Average Payables of 771.1 K will help investors to properly organize and evaluate Psyence Biomedical financial condition quickly.
Psyence |
About Psyence Financial Ratios Analysis
Psyence BiomedicalFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Psyence Biomedical investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Psyence financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Psyence Biomedical history.
Psyence Biomedical Financial Ratios Chart
Add Fundamental
Stock Based Compensation To Revenue
A metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards.Research And Ddevelopement To Revenue
The ratio of a company's research and development expenses to its total revenue, indicating how much of the revenue is invested back into developing new products or services.Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Most ratios from Psyence Biomedical's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Psyence Biomedical current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Psyence Biomedical Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. Current Ratio is likely to drop to 0.09 in 2024. Company Equity Multiplier is likely to drop to -0.11 in 2024
Psyence Biomedical fundamentals Correlations
Click cells to compare fundamentals
Psyence Biomedical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Psyence Stock Analysis
When running Psyence Biomedical's price analysis, check to measure Psyence Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psyence Biomedical is operating at the current time. Most of Psyence Biomedical's value examination focuses on studying past and present price action to predict the probability of Psyence Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psyence Biomedical's price. Additionally, you may evaluate how the addition of Psyence Biomedical to your portfolios can decrease your overall portfolio volatility.